Showing results (61-70 of 144) with videos related to
Sort By:
Pageof 15
American Journal of Nephrology|August 16, 2018
When to Stop Eculizumab in Complement-Mediated Thrombotic MicroangiopathiesSven R Olson, Eric Lu, Emilio Sulpizio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology GroupChristopher W Ryan, Bryan H Goldman, Primo N Lara, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Reversing transgene silencing via targeted chromatin editingSebastian Palacios, Elia Salibi, Eric Lu, et al.Cancer|April 23, 2008
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trialTomasz M Beer, Alshad S Lalani, Stella Lee, et al.Nature Communications|December 4, 2015
Ultralight shape-recovering plate mechanical metamaterialsKeivan Davami, Lin Zhao, Eric Lu, et al.Journal for Immunotherapy of Cancer|July 27, 2024
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohortSandip P Patel, Megan Othus, Young Kwang Chae, et al.Pediatric Blood & Cancer|September 28, 2012
Overcoming autopsy barriers in pediatric cancer researchJennifer L Alabran, Jody E Hooper, Melissa Hill, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2025
Ribociblib in Sequential Combination with Doxorubicin in Anthracycline-Naive Advanced Soft Tissue Sarcomas: Results of a Dose-Finding Phase 1B StudyLara E Davis, Limin Zhu, Emile Latour, et al.Journal for Immunotherapy of Cancer|October 21, 2025
Multicenter phase II trial of ipilimumab and nivolumab in metastatic or unresectable perivascular epithelioid cell tumor (PEComa): a substudy of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609 (Cohort 38)Sandip P Patel, Megan Othus, Young K Chae, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortiumJonathan E Rosenberg, Charles J Ryan, Vivian K Weinberg, et al.Pageof 15